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Original Article
Cocaine abuse has markedly increased over the past
decade having reached epidemic levels in Western coun-
tries 1-4. Cocaine intoxication is associated with a significant
morbidity and mortality and is a frequent cause of drug-rela-
ted sudden death 2,3. Most evidence suggests that cocaine-
induced sudden death results from its cardiovascular con-
sequences, particularly ventricular arrhythmias 1. However,
the mechanisms involved in the genesis of these arrhy-
thmias remain incompletely understood. Although cocaine-
induced arrhythmias may be associated with myocardial
ischemia or infarction 3,5, cocaine may be arrhythmogenic in
the absence of an ischemic event 1. In addition to its power-
ful indirect sympathomimetic actions 1-4 (promoted by blo-
ckade of presynaptic reuptake of norepinephrine and dopa-
mine), high doses of cocaine exert significant local anesthe-
tic effects that could promote conduction disturbances and
reentrant arrhythmias 1,3,6,7. Nevertheless, experimental stu-
dies evaluating cocaine’s effects on programmed electrical
stimulation-induced arrhythmias have had conflicting
results, with cocaine either increasing or having a neutral
effect on inducibility of ventricular arrhythmias 6,8-11. Fur-
ther, although supraventricular tachyarrhythmias, inclu-
ding atrial tachycardia, atrial flutter, and atrial fibrillation, can
also occur in the setting of cocaine abuse 1,3,12-14, limited data
are is available assessing the impact of the drug on induci-
bility of atrial arrhythmias.
Therefore, we sought to characterize the actions of
high plasma concentrations of cocaine on atrial and ventri-
cular electrophysiology and arrhythmia inducibility in a
canine preparation with normal hearts.
Methods
Beagle dogs (n=12; weight, 9-13 kg) were divided into
2 groups: cocaine (n=8) and sham control (n=4). The study
protocol was approved by the research committee of the
Objective - To characterize the cardiac electrophy-
siologic effects of cocaine.
Methods - In 8 dogs (9-13 kg), electrophysiologic
parameters and programmed stimulation were undertaken
using transvenous catheters at baseline, and after cocaine
intravenous infusion (12 mg/kg bolus followed by 0.22 mg/
kg/min for 25 minutes).
Results - Cocaine plasma levels (n=5) rose to 6.73±
0.56 µg/mL. Cocaine did not affect sinus cycle length and
arterial pressure. Cocaine prolonged P wave duration
(54±6 vs 73±4 ms, P<0.001), PR interval (115±17 vs
164±15 ms, P<0.001), QRS duration (62±10 vs 88±14 ms,
P<0.001), and QTc interval (344±28 vs 403±62 ms,
P=0.03) but not JT interval (193±35 vs 226±53 ms, NS).
Cocaine prolonged PA (9±6 vs 23±8 ms, P<0.001), AH
(73±16 vs 92±15 ms; P=0.03), and HV (35±5 vs 45±3ms;
P<0.001) intervals and Wenckebach point (247±26 vs
280±28 ms, P=0.04). An increase occurred in atrial
(138±8 vs 184± 20 ms; P<0.001) and ventricular (160±15
vs 187±25 ms; P=0.03) refractoriness at a cycle length of
300 ms. Atrial arrhythmias were not induced in any dog.
Ventricular fibrillation (VF) was induced in 2/8 dogs at
baseline and 4/8 dogs after cocaine.
Conclusion - High doses of cocaine exert significant
class I effects and seem to enhance inducibility of VF but
not of atrial arrhythmias.
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Federal University of São Paulo and was conducted accor-
ding to guidelines of the American Society of Physiology.
Animals were premedicated with morphine (2 mg/kg
IM). After 15 minutes, dogs were anesthetized (propofol, 6-
8 mg/kg IV), intubated, placed on a fluoroscopy table and
mechanically ventilated with room air and supplemental
oxygen. Anesthesia was maintained by an intravenous in-
fusion of propofol (100 µg/k/min) administered with an infu-
sion pump. Body temperature was maintained at 37°C with a
heating blanket. Continuous electrocardiogram (ECG) and
pulse oximetry monitoring were performed. The right exter-
nal jugular and both femoral veins were cannulated for
fluids and drug administration, whereas the right femoral
artery was cannulated for arterial blood sampling and inva-
sive pressure monitoring. Blood gases and pH were monito-
red and maintained within physiological ranges.
Standard 6F quadripolar mapping catheters were in-
troduced via the jugular and femoral veins and placed in the
right atrial appendage, right ventricular apex and His bundle
position under fluoroscopy guidance. Surface ECG and bi-
polar intracardiac electrograms filtered at 30-500 Hz were
displayed on a monitor and stored on optical disk by a stan-
dard computerized recording system (Tecnologia Eletrônica
Brasileira, São Paulo, Brazil) that also features a programma-
ble electrical stimulator.
The sinus cycle length, surface electrocardiographic
(P, PR, QRS, QT, corrected QT, JT) and intracardiac conduc-
tion (PA, AH, HV) intervals were measured during sinus
rhythm as previously reported. The antegrade Wenckebach
point was determined with usual techniques 15. The effecti-
ve refractory period (ERP) of the atrium and ventricle were
measured during continuous pacing at 300 ms cycle leng-
ths at 4 times the threshold and a pulse width of 2.0 ms with
the decremental stimulus technique. After 2 minutes of con-
tinuous pacing, a premature stimulus (S2) was introduced
after every 8 basic (S1) stimuli, with the S1S2 interval
decreased by 10 ms decrements until failure to capture oc-
curred. ERP was defined as the longest extrastimulus cou-
pling interval (S1S2) that failed to produce a propagated res-
ponse 3 consecutive times. Inducibility of atrial and ventri-
cular arrhythmias was assessed at a cycle length of 300 ms
with up to 3 extrastimuli. Rapid burst pacing for 15 seconds
at a 200 ms cycle length was undertaken during atrial stimu-
lation only. Atrial and ventricular tachyarrhythmias longer
than 30 seconds in duration or resulting in hemodynamic
collapse were considered sustained. Atrial electrophysiolo-
gic measurements were made prior to initiating ventricular
stimulation. Arterial pressures were determined at least 5
minutes after any pacing maneuvers during sinus rhythm.
In 8 dogs, cocaine hydrochloride (from the Federal Uni-
versity of São Paulo) was freshly dissolved in isotonic sa-
line and administered (12 mg/kg bolus for 5 minutes follo-
wed by 0.22 mg/kg/min for 25 min) via the femoral venous
access with an infusion pump. Surface ECG, electrophysio-
logic and hemodynamic parameters and arrhythmia induci-
bility were assessed at baseline and 30 minutes after initia-
tion of cocaine infusion. Sham control dogs (n=4) under-
went the same protocol, but a benign vehicle (0.9% saline)
was given instead of cocaine.
Arterial blood samples were obtained just prior to elec-
trophysiologic measurements. Blood was collected into he-
parinized tubes containing sodium fluoride, immediately
placed on ice, and centrifuged at 4oC. Plasma was separated
and stored at -20oC until the assay. Plasma cocaine levels
were determined by gas chromatography mass spectrome-
try as previously described 16.
Results are reported as mean±1SD. The Student t test
and the Fisher’s test were used as appropriate. A P value
<0.05 was considered significant.
Results
The electrophysiologic effects of cocaine were eva-
luated in 8 dogs. Cocaine plasma levels were available in 5
dogs and increased to 6.73±0.56 µg/mL (range 5.90-7.20).
These levels correspond to those reported in the setting of
cocaine abuse 1,6.
Hemodynamic, electrocardiographic, and electrophy-
siologic effects (tab. I) - Infusion of cocaine did not signifi-
cantly affect systolic (116±39 vs 141±33 mmHg, NS) and
diastolic (63±19 vs 85±26, P=0.07) arterial pressure. In addi-
tion, no changes in sinus cycle length (539±83 vs 626±
126 ms, NS) were noted. However, as illustrated in figure 1,
cocaine prolonged P wave duration (54±6 vs 73±4 ms,
P<0.001) and QRS duration (62±10 vs 88±14 ms, P<0.001). Of
note, the percent increase in P wave duration was similar to
the increase in QRS duration (respectively, 37%, 19±5 ms vs
51%, 30±22 ms; NS). The PR interval (115±17 vs 164±15,
P<0.001), QT interval (252±34 vs 317±73 ms, P=0.04) and
QTc interval (344±28 vs 403±62 ms, P=0.03) were prolonged
as well but the JT interval (193±35 vs 226±53 ms, NS) did not
change. Cocaine also prolonged PA (9±6 vs 23±8 ms,
P<0.001), AH (73±16 vs 92±15 ms; P=0.03), and HV (35±5 vs
45±3ms; P<0.001) intervals as well as the Wenckebach point
(247±26 vs 280±28 ms, P=0.04). Cocaine-induced prolonga-
tion of electrocardiographic and intracardiac intervals ap-
peared to be rate-dependent. That is, the increase in these
intervals became progressively larger as the pacing cycle
length was decreased (fig. 2). However, because of drug-
induced increases in atrioventricular node refractoriness,
this phenomenon could be demonstrated in 3 dogs only.
Further, cocaine induced a marked increase in atrial (138±8
vs 184±20 ms; P<0.001) and ventricular (160±15 vs 187±25
ms; P=0.03) ERP at a paced cycle length of 300 ms. Cocaine
produced a greater increase in atrial ERP than in ventricular
ERP (32%, 45±20 ms vs 18%, 27±20 ms; P=0.08). No chan-
ges in hemodynamic and electrophysiologic parameters
occurred in sham controls (tab. II).
Spontaneous atrial and ventricular arrhythmias did not
occur after cocaine administration. Notably, despite aggres-
sive stimulation protocols, atrial arrhythmias were not indu-
ced in any dog, either at baseline or after cocaine infusion.
Ventricular fibrillation (VF) could be induced in 2/8 (25%)
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difference was not statistically significant. Both animals that
had VF induced at baseline also had the arrhythmia following
cocaine injection. In a single dog, monomorphic ventricular
tachycardia was induced after cocaine injection and was
interrupted by rapid ventricular pacing. Ventricular fibrillation
could also be induced in this dog (fig. 3). In all these animals,
induction of sustained ventricular arrhythmias required the
application of triple extrastimuli. Spontaneous or induced
arrhythmias did not occur in any sham control animal.
Discussion
The present study has demonstrated in dogs with nor-
mal hearts and intact autonomic nervous system that intra-
venous cocaine, at doses resulting in plasma levels com-
parable to those reported in the setting of cocaine intoxica-
tion 1,6, has remarkable atrial and ventricular electrophysio-
logic effects. Cocaine has been found to significantly slow
conduction in the atrium, AV node, His-Purkinje system, and
ventricles. In addition, cocaine induced a marked increase in
atrial and ventricular refractoriness. Nevertheless, cocaine
did not produce spontaneous arrhythmias and had no ef-
fect on electrical induction of atrial arrhythmias, but appea-
red to modestly increase inducibility of ventricular arrhyth-
mias. These results cannot be attributed to the animal pre-
paration, because changes in hemodynamic and electrophy-
siologic parameters did not occur in sham controls.
A consistent finding in all dogs was that high-doses
of cocaine produced significant conduction-slowing effects
on cardiac tissues (fig. 1). Cocaine slowed conduction in the
atrium (P wave duration and PA interval), AV node (AH
interval), His-Purkinje system (HV interval), and ventricle
(QRS duration). Further, these actions seemed to be use-
and rate-dependent, or in other words, they became pro-
gressively larger as the heart rate was increased (fig. 2). Our
results are in agreement with previous reports 1,3,6 that have
shown in canine models that cocaine has conduction-
slowing characteristics similar to class IB antiarrhythmic
agents (lidocaine and mexiletine). Notably, these effects are
modulated by the autonomic nervous system and are exa-
cerbated following combined muscarinic and β1 adrenergic
blockade 6. Further supporting these findings, it has been
demonstrated in isolated ventricular myocytes that cocaine
depresses the cardiac sodium current in both a use- and rate-
dependent manner, with kinetics of interaction with sodium
channels that approximates that reported for lidocaine 17.
In accordance with previous investigations 6,18, the
present study has clearly shown that high-dose cocaine
markedly increases atrial and ventricular refractoriness.
Fig. 1 - Cocaine’s effects on electrocardiographic and intracardiac intervals are
exemplified. From top to bottom: ECG leads II, III, and AVF, and bipolar electrograms
recorded from the right ventricular apex (RV), high right atrium (HRA), and His
bundle (His). The atrial (A), ventricular (V) and His bundle (H) electrograms are
indicated. Tracings during sinus rhythm before (baseline) and after cocaine
administration (cocaine). Note the marked drug-induced prolongation of electro-
cardiographic and intracardiac intervals. Paper speed at 100 mm/s.
Table I - Hemodynamic, electrocardiographic, and electrophysiologic effects of cocaine in 8 dogs
Baseline Cocaine P value
SAP (mmHg) 116±39 (75-198) 141±33 (87-180) <NS
DAP (mmHg) 63±19 (45-100) 85±26 (49-117) <0.07
Heart rate (ms) 539±83 (375-638) 626±126 (400-767) <NS
P wave duration (ms) 54±6 (40-60) 73±4 (70-80) <0.001
PR interval (ms) 115±17 (86-140) 164±15 (134-185) <0.001
QRS duration (ms) 62±10 (50-70) 88±14 (70-150) <0.001
QTc interval (ms) 344±28 (311-400) 403±62 (350-540) <0.03
JT interval (ms) 193±35 (144-250) 226±53 (150-320) <NS
Wenckebach point (ms) 247±26 (200-285) 280±28 (250-340) <0.04
PA interval (ms) 9±6 (0-20) 23±8 (10-35) <0.001
AH interval (ms) 73±16 (40-90) 92±15 (60-110) <0.03
HV interval (ms) 35±5 (30-40) 45±3 (40-65) <0.001
Atrial ERP (ms) 138±8 (130-150) 184±20 (150-210) <0.001
Ventricular ERP (ms) 160±15 (130-180) 187±25 (150-220) <0.03
Data expressed as mean ± standard deviation and range. DAP- indicates diastolic arterial pressure; ERP- effective refractory period; NS- nonsignificant; QTc, corrected
QT; SAP, systolic arterial pressure. See text for details.
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Interestingly, as reported by Clarkson et al 6, this effect
seems to be more pronounced in the atrium as compared to
the ventricle, although this difference did not reach signi-
ficance (P=0.081) in our study. Although cocaine has been
shown to depress both calcium and potassium currents18,19,
most of cocaine-induced ERP prolongation may be attribu-
ted to its potent class I effects 18. In addition to slowing
action potential upstroke velocity, sodium channel blocking
drugs delay the time-dependent recovery of excitability,
thus prolonging refractoriness beyond repolarization, a
phenomenon called postrepolarization refractoriness 20. In
support of this hypothesis, the present study and another 6
have demonstrated that cocaine increases the QT interval
without affecting the JT interval. This evidence indicates
that cocaine-induced QT lengthening results from QRS
prolongation and suggests that the drug does not primarily
affect ventricular repolarization. Noteworthy, cocaine’s
class I effects appear to be dose-dependent: at low doses
(2.1 mg/k, IV), cocaine decreased ventricular ERP and did
not affect right intra-atrial conduction, QRS or QTc 9.
In our investigation, the electrophysiological effects
of cocaine were not accompanied by significant changes in
arterial blood pressure and sinus cycle length. However,
Clarkson et al 6 have shown that cocaine, at doses resulting
in plasma levels similar to those achieved in the present
study, does not affect arterial pressures either but increases
heart rate. On the other hand, in dogs undergoing combined
(muscarinic and β1 adrenergic) autonomic blockade, cocai-
ne decreased arterial pressures and heart rate suggesting
that the depressant effects of cocaine on blood pressure
and sinus node automaticity are offset by the autonomic
nervous system. Further, it has been reported that the hemo-
dynamic response to cocaine correlates strongly with plas-
ma adrenaline levels but not with plasma cocaine levels 8.
Accordingly, in vitro studies have indicated that cocaine
has direct depressant effects on tissues isolated from the
sinus node 18,21. Therefore, the discrepancy in heart rate res-
ponse to cocaine between the 2 studies may be accounted
for by variations in autonomic tone secondary to different
animal preparations.
In our study, in spite of aggressive stimulation proto-
cols, cocaine did not increase inducibility of atrial arrhyth-
mias but seemed to modestly enhance electrical induction
of sustained ventricular arrhythmias (50% vs 25% in con-
trols). Clarkson et al 6 obtained similar figures. They repor-
ted that in the presence of cocaine, at doses comparable to
those used in the present study, sustained VT/VF could be
induced in 2/10 (20%) dogs as compared to 0/13 (0%) con-
trols. In dogs undergoing autonomic blockade, sustained
VT/VF was induced in 2/6 (33%) dogs vs 0/12 (0%) controls.
However these numbers did not reach statistical significan-
ce. In addition, the incidence of inducible sustained ventri-
cular arrhythmias was further increased (33% without auto-
nomic blockade) at higher cocaine plasma levels. In con-
trast, Tisdale et al 10 have reported that cocaine did not sig-
nificantly decrease VF threshold. Further, Schwartz et al 8 ha-
ve shown in conscious dogs that low-dose cocaine (2.8 mg/
kg, IV) does not result in induced ventricular arrhythmias
but increases susceptibility to atrial fibrillation (3/14 dogs).
Except for the latter, inducibility of atrial arrhythmias was not
assessed in these studies. As opposed to the findings of
Schwartz et al 8, inducible atrial arrhythmias did not occur in
the present study. The reasons for that are unclear but
could be connected to the higher cocaine doses used in our
investigation. The wavelength (ie, product of refractory pe-
riod and conduction velocity) is a critical determinant of in-
ducibility of reentrant arrhythmias 22. Shorter wavelengths
are more likely to set up reentrant circuits than longer wave-
lengths. In agreement with our findings, in vitro studies
have shown that right atrial cells exhibit a greater increase in
action potential duration and ERP than right ventricular
cells, at each cocaine concentration 18. Furthermore, cocai-
ne has been found to equally slow conduction in the atrium
and ventricle 6. Theoretically, in a reentrant circuit with a
fixed path length, this situation would result in relatively
longer wavelengths in the atrium as compared to the ventri-
cle. Therefore, although the wavelength of excitation was
Fig. 2 - Cocaine’s marked rate-dependent effects on conduction are depicted. The
ECG lead II and bipolar electrograms recorded from the His bundle (His) during
continuous right atrial pacing at progressively shorter cycle lengths (S1S1) are
shown. The atrial (A), ventricular (V), and His bundle (H) electrograms are indicated.
At baseline (panel A), shortening of S1S1 from 400 to 300 ms results in physiologi-
cal prolongation of the AH interval without changes in QRS duration and HV inter-
val. Note that after cocaine (panel B), drug-induced prolongation of electrocardio-
graphic and intracardiac intervals are already apparent at a pacing cycle length of
600 ms, becoming progressively larger as the pacing cycle length was decreased to
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not directly measured in this study, it is tempting to specula-
te that cocaine’s differential effects on inducibility of atrial
and ventricular arrhythmias may be related in part to diffe-
rent drug-induced changes in wavelength mediated by alte-
rations in action potential duration and conduction. Howe-
ver, it is important to remark that small (9-13 kg) dogs were
used in our study, which takes on much greater importance
because reentrant arrhythmias are less likely to occur in
small-sized atria 22. Hence, further studies are needed to con-
firm our observation that high plasma levels of cocaine do
not render the atrium susceptible to inducible arrhythmias.
The modest effects of cocaine on inducibility of atrial
and ventricular arrhythmias and also on production of
spontaneous arrhythmias are consistent with the hypothe-
sis that the development of malignant arrhythmias in the
setting of cocaine intoxication may require additional pa-
thological conditions, such as metabolic disturbances or
myocardial ischemia 1,3. Accordingly, it has been shown that
cocaine increases the frequency of spontaneous and indu-
ced ventricular arrhythmias in the presence of myocardial
infarction or a hyperadrenergic state 8,11,23. Interestingly, in
one of these series 23, spontaneous supraventricular arrhy-
thmias and sustained atrial fibrillation were noted in dogs
receiving low-dose cocaine (0.5 mg/kg, IV) plus norepine-
phrine, whereas dogs receiving cocaine alone had no arrhy-
thmias. Notwithstanding these observations, it is impor-
tant to point out that cocaine per se may promote or exacer-
bate cardiac arrhythmias. The sympathomimetic actions of
cocaine could lead to automatic or triggered arrhythmias 19.
Further, because of its prominent conduction-slowing ef-
fects (class I effects), cocaine may shorten the excitation
wavelength or create areas of unidirectional block, thus
providing the conditions for reentry 1,3,6,7. Notably, these
class I effects are markedly modulated by the autonomic
nervous system and heart rate 6. As evidenced by this and
other studies 6, sustained monomorphic VT and VF may be
induced in the setting of cocaine abuse (fig. 3). In addition,
several clinical reports 1-4,12-14,24 have documented that
cocaine may lead to conduction disturbances, supraventri-
cular and ventricular arrhythmias, and sudden death in the
absence of myocardial ischemia or heart disease. Further
supporting this premise, the proarrhythmic effects of so-
dium channel blocking drugs are well recognized, particu-
larly in the presence of structural heart disease 25.
The present study evaluated the acute electrophysio-
logic effects of cocaine in a dog model with normal hearts. In
addition, concomitant ethanol ingestion and cigarette smo-
king exacerbate the deleterious effects of cocaine on the
heart 3,26. Thus, our findings may not apply directly to hu-
mans with structural heart diseases, long-term cocaine
users, or those using additional drugs. The effects of cocai-
ne on coronary circulation were not assessed. However,
electrocardiographic manifestations of acute myocardial
ischemia or infarction were not noted in any dog.
In conclusion, in this dog model, high-doses of cocai-
ne exert significant class I effects on the atrium, AV node,
Table II - Hemodynamic, electrocardiographic, and electrophysiologic parameters in 4 sham control dogs
Baseline Saline P value
SAP (mmHg) 143±38 (105-194) 146±26 (114-180) NS
DAP (mmHg) 94±15 (78-112) 93±13 (75-105) NS
Heart rate (ms) 476±109 (343-571) 511±64 (472-571) NS
P wave duration (ms) 55±6 (50-60) 56±5 (50-60) NS
PR interval (ms) 107±28 (70-133) 105±26 (70-133) NS
QRS duration (ms) 66±5 (60-70) 67±5 (60-70) NS
QTc interval (ms) 390±54 (353-470) 378±61 (333-470) NS
JT interval (ms) 170±21 (150-200) 170±20 (153-200) NS
Wenckebach point (ms) 220±28 (200-260) 217±12 (200-230) NS
PA interval (ms) 5±5 (0-10) 3±5 (0-10) NS
AH interval (ms) 66±20 (40-85) 65±19 (40-80) NS
HV interval (ms) 36±5 (30-40) 34±4 (30-40) NS
Atrial ERP (ms) 147±17 (130-170) 145±17 (130-170) NS
Ventricular ERP (ms) 157±5 (150-160) 155±5 (150-160) NS
Data expressed as mean ± standard deviation and range. DAP- indicates diastolic arterial pressure; ERP- effective refractory period; NS- nonsignificant; QTc, corrected
QT; SAP, systolic arterial pressure. See text for details.
Fig. 3 - Sustained ventricular arrhythmias induced with triple extrastimuli during
cocaine intoxication in the same dog. From top to bottom: ECG leads I and II, and
bipolar electrograms recorded from the right ventricular apex (RV) and high right
atrium (HRA). The atrial (A) and ventricular (V) electrograms are indicated. In panel
A, a monomorphic ventricular tachycardia with a cycle length of 240 ms is shown,
whereas ventricular fibrillation is depicted in panel B. Paper speed at 25 mm/s.
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His-Purkinje system, and ventricles. In addition, cocaine
seems to modestly enhance inducibility of ventricular fibril-
lation but not of supraventricular arrhythmias. These findin-
gs further suggest that cocaine has direct myocardial ac-
tions that may create a substrate for the development of
proarrhythmias.
